Ireland· IE-PA-EU/1/25/1912/002
Voranigo 40 mg film-coated tablets
A vorasidenib product containing vorasidenib hemicitrate hemihydrate, registered in Ireland by Les Laboratoires Servier. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Vorasidenib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01XM04 (vorasidenib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Vorasidenib · ATC L01XM04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Vorasidenib hemicitrate hemihydrate
- Manufacturer
- Les Laboratoires Servier
- Country
- Ireland (IE)
- ATC code
- L01XM04
- ATC class
- Vorasidenib
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/25/1912/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vorasidenib in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3a244c17-3f32-4f97-aaed-b8d6c5e3fc3f GET /v1/drugs/3a244c17-3f32-4f97-aaed-b8d6c5e3fc3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XM04"
],
"strength": null,
"pa_number": "EU/1/25/1912/002",
"substances": [
"Vorasidenib hemicitrate hemihydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "17/09/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about vorasidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.